desc,gpt4
asthma,1.0
asthma with exacerbation,1.0
allergic rhinitis,0.6
albuterol,1.0
montelukast,1.0
fluticasone,1.0
chronic obstructive asthma,1.0
wheezing,0.85
cough,0.65
fluticasone / salmeterol,1.0
chronic obstructive asthma with exacerbation,1.0
other diagnostic procedures on lung and bronchus,0.65
cetirizine,0.25
other symptoms of respiratory system,0.5
albuterol / ipratropium,1.0
dog dander ige,0.75
budesonide,1.0
acute bronchitis and bronchiolitis,0.25
american house dust mite ige,0.65
cat dander ige,0.65
alternaria alternata ige,0.75
acute upper respiratory infections of multiple or unspecified sites,0.25
chronic pharyngitis and nasopharyngitis,0.1
bronchitis,0.6
aspergillus fumigatus ige,0.65
azithromycin,0.1
white oak (quercus alba) ige,0.2
timothy (phleum pratense) ige,0.25
common ragweed (ambrosia elatior) ige,0.25
chronic airway obstruction,0.85
chronic bronchitis,0.4
dermatophagoides pteronyssinus ige,0.25
allergic reaction to food,0.1
fexofenadine,0.25
cladosporium herbarum ige,0.65
obstructive chronic bronchitis,0.75
mometasone,0.85
"esophagitis, gerd and related diseases",0.1
loratadine,0.7
gerd,0.1
white ash (fraxinus americana) ige,0.25
budesonide / formoterol,1.0
tobacco use disorder,0.25
american beech (fagus grandifolia) ige,0.25
ige,0.7
prophylactic vaccinations and inoculations,0.1
eastern white pine (pinus strobus) ige,0.25
tiotropium,0.85
white birch (betula populifolia) ige,0.25
mugwort (artemisia vulgaris) ige,0.75
hazelnut (corylus avellana) ige,0.2
beclomethasone dipropionate,1.0
mouse epithelium ige,0.2
penicillium notatum ige,0.2
salmeterol,1.0
kentucky blue grass (poa pratensis) ige,0.25
shortness of breath,0.85
"overweight, obesity and other hyperalimentation",0.1
brazil nut (bertholletia excelsa) ige,0.25
diseases of esophagus,0.05
triamcinolone,0.75
chronic sinusitis,0.25
goosefoot (chenopodium album) ige,0.25
"allergies, other",0.25
obesity,0.25
giant ragweed (ambrosia trifida) ige,0.25
migraine,0.05
acute sinusitis,0.1
codeine / guaifenesin,0.25
pistachio (pistacia vera) ige,0.25
ipratropium,0.85
atopic/contact dermatitis due to other or unspecified,0.1
cockroach (blatella germanica) ige,0.85
walnut (juglans spp) ige,0.2
benzonatate,0.25
theophylline,0.85
cottonwood (populus deltoides) ige,0.85
allergic conjunctivitis,0.2
acute pharyngitis,0.1
cashew nut (anacardium occidentale) ige,0.25
pine nut (pinus edulis) ige,0.25
urticaria,0.1
white elm (ulmus americana) ige,0.25
rast panel/testing (group:rastp),0.85
bermuda grass (cynodon dactylon) ige,0.25
johnson grass (sorghum halepense) ige,0.65
"conjunctivitis, noninfectious",0.05
trout (oncorhynchus mykiss) ige,0.1
omalizumab,1.0
fusarium moniliforme ige,0.1
chestnut (castanea sativa) ige,0.2
cocksfoot (dactylis glomerata) ige,0.25
"anxiety, phobic and dissociative disorders",0.05
mite dust ige,0.85
setomelanomma rostrata ige,0.0
pecan or hickory nut (carya illinoinensis nut) ige,0.25
boxelder (acer negundo) ige,0.25
almond (prunus dulcis) ige,0.25
azelastine,0.85
umeclidinium,0.9
epinephrine,0.75
nasal polyps,0.25
"injection, mepolizumab, 1 mg",1.0
zileuton,1.0
acute bronchospasm,0.85
irritable bowel syndrome,0.05
menopausal and postmenopausal disorders,0.05
bronchiectasis,0.25
symptomatic menopause,0.0
postnasal drip,0.25
elevated blood pressure reading without diagnosis of hypertension,0.05
"other diagnostic procedures (interview, evaluation, consultation)",0.25
noninflammatory female genital disorders,0.0
sleep disorders,0.1
zafirlukast,1.0
abnormal findings on mammogram or breast exam,0.0
formoterol / mometasone,1.0
mammography,0.0
sleep apnea,0.2
"disorders of uterus, nec",0.0
septal deviations/turbinate hypertrophy,0.25
other headache syndromes,0.0
palpitations,0.1
back pain,0.0
hyperlipidemia,0.0
disorders of lipoid metabolism,0.05
herpes simplex,0.0
essential hypertension,0.05
heartburn,0.0
fasciitis,0.0
migrain with aura,0.0
myalgia and myositis unspecified,0.05
acne,0.0
abnormal papanicolaou smear of cervix and cervical hpv,0.0
"other diagnostic procedures, female organs",0.0
sumatriptan,0.0
eustachian tube disorders,0.05
benign mammary dysplasias,0.0
disorders of menstruation and other abnormal bleeding from female genital tract,0.0
high density lipoprotein cholesterol,0.05
pneumoconiosis,0.1
emphysema,0.2
abnormal mammogram,0.0
benign neoplasm of uterus,0.0
uterine leiomyoma,0.0
abnormal glucose,0.05
anaphylactic shock nos,0.2
aerochamber,0.85
symptoms involving female genital tract,0.0
"stress incontinence, female",0.0
cervicalgia,0.0
triglycerides,0.05
rosacea,0.0
"rheumatism, unspecified and fibrositis",0.0
zolmitriptan,0.0
sarcoidosis,0.1
Bordetella parapertussis DNA,0.05
latex ige,0.25
albuterol 2.5mg w/ipratrop 0.5mg(via upmc dme),1.0
bacteria identified,0.1
prednisone,0.85
procalcitonin study day 5,0.05
procalcitonin study day 3,0.05
methylprednisolone,0.75
drug unknown,0.1
Bordetella pertussis Ag,0.1
consult / referral to the comprehensive lung center,0.75
unspecified perpetrator of maltreatment and neglect,0.0
caffeine / ergotamine,0.05
latex ab.ige.rast class,0.25
osteoarthrosis nos,0.0
pirbuterol,1.0
procalcitonin study day 1,0.05
Bordetella pertussis DNA,0.1
easivent,0.2
chlorpheniramine-hydrocod8-10mg/5mlud,0.75
azithromycin_250mg_tablet_2_pak,0.1
cefaclor,0.1
t4 (mwh only),0.0
family history of asthma,0.8
rape,0.0
nonspecific chest pain,0.25
abnormal heart sounds,0.1
acetaminophen-hydrocodone,0.0
amoxicillin-clavulanate,0.0
"male partner, perpetrator of maltreatment and neglect",0.0
personal history of physical and sexual abuse in childhood,0.0
anxiety disorder,0.1
cladosporium herbarum ab.ige.rast class,0.25
obstructive sleep apnea,0.2
mood disorders,0.0
nebulizer (compressor and supplies),0.85
other reasons for seeking consultation,0.1
acer negundo ab.ige.rast class,0.0
bipolar,0.0
interpretation-colovantage (trademark),0.0
procalcitonin study day 2,0.05
quercus alba ab.ige.rast class,0.1
lithium_125mg/2.1ml_syrup_ud,0.0
phleum pratense ab.ige.rast class,0.25
long term (current) use of inhaled steroids,1.0
ra nac 60ct,0.0
english plantain (plantago lanceolata) ige,0.2
encounters for unspecified administrative purpose,0.0
flutter valve,0.05
total eosinophil count,0.65
other respiratory therapy,0.5
person feigning illness,0.0
plantago lanceolata ab.ige.rast class,0.2
homatropine / hydrocodone,0.1
ciclesonide,1.0
calamine / zinc oxide topical product,0.01
cromolyn,0.9
excessive vomiting in pregnancy,0.0
penicillin g benzathine,0.0
sesame seed (sesamum indicum) ige,0.25
toxic effect of noxious substances eaten as food,0.1
peanut (arachis hypogaea) ige,0.2
pimecrolimus topical product,0.1
crab (cancer pagurus) ige,0.05
shrimp (pandalus borealis) ige,0.25
silver birch (betula verrucosa) ige,0.25
blue mussel (mytilus edulis) ige,0.25
lobster (homarus gammarus) ige,0.2
codfish (gadus morhua) ige,0.2
salmon (salmo salar) ige,0.2
tuna (thunnus albacares) ige,0.1
levocetirizine,0.25
other diagnostic procedures on skin and subcutaneous tissue,0.0
casein ige,0.25
Poppy Seed (Papaver somniferum) IgE,0.2
deprecated s pneum12 igg ser-mcnc,0.05
Streptococcus pneumoniae Danish serotype 19F IgG,0.05
Streptococcus pneumoniae Danish serotype 3 IgG,0.05
streptococcus pneumoniae danish serotype 18c igg,0.05
deprecated s pneum4 igg ser-mcnc,0.0
Streptococcus pneumoniae Danish serotype 4 IgG,0.05
streptococcus pneumoniae danish serotype 9v igg,0.0
deprecated s pneum9 igg ser-mcnc,0.1
Streptococcus pneumoniae Danish serotype 23F IgG,0.05
deprecated s pneum23 igg ser-mcnc,0.1
Streptococcus pneumoniae Danish serotype 12F IgG,0.05
deprecated s pneum 1 igg ser-mcnc,0.1
Streptococcus pneumoniae Danish serotype 5 IgG,0.05
deprecated s pneum3 igg ser-mcnc,0.1
Streptococcus pneumoniae Danish serotype 8 IgG,0.05
Streptococcus pneumoniae serotype IgG,0.05
streptococcus pneumoniae danish serotype 6b igg,0.05
deprecated s pneum14 igg ser-mcnc,0.1
deprecated s pneum19 igg ser-mcnc,0.1
streptococcus pneumoniae danish serotype 7f igg,0.05
deprecated s pneum5 igg ser-mcnc,0.1
Streptococcus pneumoniae Danish serotype 1 IgG,0.05
Streptococcus pneumoniae Danish serotype 14 IgG,0.05
Streptococcus pneumoniae Danish serotype 9N IgG,0.05
deprecated s pneum8 igg ser-mcnc,0.1
"Mouse epithelium, serum proteins + urine proteins IgE",0.85
Beta lactoglobulin IgE,0.25
lactalbumin alpha ige,0.2
otitis media,0.05
horse dander ige,0.7
Alternaria sp IgE,0.75
goose feather ige,0.25
"influenza virus vaccine, inactivated",0.1
Aspergillus sp Ab,0.25
Aspergillus sp IgE,0.65
coconut (cocos nucifera) ige,0.2
carrot (daucus carota) ige,0.25
blatella germanica ab.ige.rast class,0.25
Allergen.miscellaneous Ab.IgE.RAST class,0.65
constipation,0.0
fungus,0.1
other tests,0.1
Penicillium sp Ab,0.1
egg white ige,0.25
beef ige,0.1
ovomucoid ige,0.65
allergy studies,0.65
other anemias,0.0
family history,0.2
depression,0.05
hypothyroidism nos,0.0
chronic pain,0.1
electrolyte imbalance,0.1
"iron deficiency anemias, unspecified or not due to blood loss",0.05
"potential health hazards related to communicable diseases
potential health hazards related to communicable diseases",0.0
insomnia,0.1
other infectious and parasitic diseases,0.05
other dyspnea,0.65
type 2 diabetes,0.05
hypertensive heart and/or renal disease,0.05
chronic renal failure [ckd],0.05
abdominal pain,0.0
poisoning/allergy of sulfonamides,0.1
screening for other diseases and disorders,0.1
"persons with potential health hazards related to socioeconomic, psychosocial, and other circumstances",0.1
tachycardia nos,0.1
screening for infectious and parasitic diseases,0.1
nausea and vomiting,0.05
adverse drug events and drug allergies,0.25
allergy/adverse effect of penicillin,0.1
coronary atherosclerosis,0.0
pain in limb,0.0
substance addiction and disorders,0.05
acquired absence of organs,0.0
adverse effects of sedatives or other central nervous system depressants and anesthetics,0.05
atrial fibrillation and flutter,0.0
osteoarthritis; localized,0.0
diarrhea,0.0
complications of transplants and reattached limbs,0.0
vitamin d deficiency,0.05
bacterial infection nos,0.05
acute renal failure,0.0
respiratory failure,0.5
pleurisy; pleural effusion,0.1
acute pain,0.1
attention deficit hyperactivity disorder,0.0
other disorders of metabolism,0.05
adjustment reaction,0.1
elevated white blood cell count,0.2
pulmonary collapse; interstitial and compensatory emphysema,0.1
rash and other nonspecific skin eruption,0.05
pneumonia,0.2
adverse effects of antibacterials (not penicillins),0.05
circulatory disease nec,0.0
mental disorders durring/after pregnancy,0.05
abnormality in fetal heart rate or rhythm,0.0
thrombocytopenia,0.05
peritoneal adhesions (postoperative) (postinfection),0.0
sickle cell anemia,0.0
other chronic nonalcoholic liver disease,0.0
malaise and fatigue,0.1
benign neoplasm of colon,0.0
osteoporosis,0.0
other disorders of bone and cartilage,0.0
disorders of magnesium metabolism,0.05
other disorders of soft tissues,0.05
"symptoms concerning nutrition, metabolism, and development",0.05
effects of other external causes,0.05
edema,0.25
vitamin b-complex deficiencies,0.05
hypovolemia,0.05
hypotension nos,0.05
"hypertension complicating pregnancy, childbirth, and the puerperium",0.05
preeclampsia and eclampsia,0.0
"abnormality of organs and soft tissues of pelvis complicating pregnancy, childbirth, or the puerperium",0.0
anemia of chronic disease,0.05
fever of unknown origin,0.05
anemia during pregnancy,0.05
cerebral ischemia,0.0
screening for malignant neoplasms,0.0
blue top hold,0.0
green top hold (plasma),0.0
light green top hold,0.0
flovent,1.0
uhold,0.0
dok,0.0
glucose,0.0
"sennosides, usp 8.6 mg oral tablet",0.0
estimated gfr (mdrd equation),0.05
length of urine collection,0.05
ventolin,1.0
"heparin sodium, porcine 5000 unt/ml injectable solution",0.0
creatinine,0.0
ph,0.0
leukocytes,0.1
specific gravity,0.05
ketone,0.05
bilirubin,0.0
urine appearance,0.0
nitrite,0.05
urobilinogen,0.0
protein,0.0
blood,0.0
urea nitrogen,0.05
fluticasone propionate 0.05 mg/actuat metered dose nasal spray,0.25
2 ml ondansetron 2 mg/ml injection,0.0
epithelial cells,0.1
rbc,0.0
yeast,0.0
bacteria,0.0
wbc,0.05
"hcg, urine, qualitative",0.0
hemoglobin,0.05
rdw,0.05
mchc,0.05
mch,0.0
red blood cells,0.05
mcv,0.0
white blood cells,0.1
urine mucous,0.1
ondansetron 4 mg disintegrating oral tablet,0.0
advair,1.0
major depressive disorder,0.05
transitional epithelial cells,0.0
mapap,0.0
platelet count,0.05
ondansetron 4 mg oral tablet,0.0
hematocrit,0.05
omeprazole 20 mg delayed release oral capsule,0.05
diphenhydramine hydrochloride 25 mg oral capsule,0.1
morbid obesity,0.1
oxycodone hydrochloride 5 mg oral tablet,0.05
vitamin b12,0.0
lorazepam 0.5 mg oral tablet,0.05
acetaminophen 325 mg oral tablet,0.05
albuterol 0.83 mg/ml inhalation solution,1.0
0.4 ml enoxaparin sodium 100 mg/ml prefilled syringe,0.0
permanent pacemaker mode,0.0
ibuprofen 400 mg oral tablet,0.1
diphenhydramine hydrochloride 2.5 mg/ml oral solution,0.25
iron,0.0
"esophagitis, gastroenteritis and miscellaneous digestive disorders without mcc",0.0
calcium carbonate 500 mg chewable tablet,0.0
folate,0.0
transferrin,0.05
"iron binding capacity, total",0.05
aluminum hydroxide 40 mg/ml / magnesium hydroxide 40 mg/ml / simethicone 4 mg/ml oral suspension,0.0
% hemoglobin a1c,0.05
gabapentin 300 mg oral capsule,0.0
pain in joint,0.0
glucagen,0.0
eag,0.0
anion gap,0.1
bicarbonate,0.1
potassium,0.0
chloride,0.05
ibuprofen 600 mg oral tablet,0.05
"calcium, total",0.01
sodium,0.0
200 actuat albuterol 0.09 mg/actuat metered dose inhaler,1.0
d-dimer,0.05
dextrose 50%,0.0
poisoning by antibiotics,0.0
exposure to tobacco smoke,0.65
"sodium chloride for aerosol (nacl), 0.9% (saline solution)",0.7
family history of non-malignant tumor,0.0
desloratadine,0.25
"adverse effect: antiasthmatics, nec",1.0
"aerius (desloratadine) 0.5 mg/ml, syrup (150ml)",0.25
"bilastine 20 mg (inorial), tablets",0.25
"mizollen 10 mg, modified-release tablets",0.1
"terbutaline - bricanyl, 500 mcg/dose spray",1.0
"primalan 5 mg, tablets",0.1
"rupatadine 10 mg, tablets",0.25
formoterol,1.0
"mometasone 50 mcg/dose (nasonex), nasal spray suspension, bottle 140 doses",0.25
beclomethasone,1.0
"beclometasone 800 mcg (chiesi lab), suspension for inhalation by nebulizer, 2 ml single-dose container",1.0
"ebastine 10 mg (lab arrow), tablets",0.75
research team,0.0
"fluticasone / vilanterol - relvar ellipta, 184 mcg/22 mcg/dose, powder for inhalation, pack 30 doses",1.0
"oxygen flow adjustment by transcutaneous monitoring of oxygen saturation, for the initiation or adjustment of a defined flow oxygen therapy in children, per 24 hours",0.75
personal history of other diseases of the respiratory system,0.5
"beclometasone 800 mcg (teva lab), suspension for inhalation by nebulizer, 2 ml single-dose container",1.0
acute laryngitis and tracheitis,0.25
other physical therapies,0.2
"tixocortol pivalate, 1% nasal powder",0.2
"ebastine 10 mg (labo biogaran), orodispersible tablets",0.75
"bilastine 10 mg (bilaska), orodispersible tablets",0.2
nasal septoplasty,0.1
"anomalies of respiratory system, congenital",0.1
fx26% positivity,0.0
"bilastine 20 mg (bilaska), tablets",0.25
mel ige positive detail,0.25
symptoms involving head and neck,0.1
chronic tonsillitis and adenoiditis,0.1
intranasal polypectomy,0.2
bilateral total ethmoidectomy by endoscopy,0.1
fx28 research,0.0
research,0.0
other upper respiratory disease,0.25
"bilateral total ethmoidectomy with nasal septoplasty, by endoscopy",0.1
"naabak (spaglumic acid) 4.9%, eye drops",0.0
e5 dog,0.0
research and development,0.0
"respiratory failure, insufficiency, arrest",0.25
"multicrom 2%, eye drops, single-dose container 0.3 ml",0.0
the cat,0.0
pcr for s. pneumoniae in bal fluid,0.1
other pulmonary inflamation or edema,0.45
ketotifen,0.85
timothy grass allergen g6,0.75
"tiotropium - spiriva respimat, 2.5 mcg/dose, inh sol, 60 dose bottle",0.85
alternaria alternata mold,0.75
acute and chronic tonsillitis,0.05
"mometasone 50 mcg/dose (arrow lab), nasal spray suspension, bottle 140 doses",0.25
endoscopic intrabronchial valve placement,0.25
suppurative and unspecified otitis media,0.05
bal pcr s.pneumo,0.2
allergen,0.75
cystitis,0.0
narcotics,0.05
cough effort,0.25
apnea,0.25
lobster,0.0
chronic cough,0.65
neupogen,0.0
sterilization,0.0
pca medication,0.2
viral enteritis,0.0
aspirin,0.05
po intake,0.0
atropine,0.1
duodenitis,0.0
aspiration site,0.05
thyroiditis,0.0
cerave,0.0
mastodynia,0.0
eribulin,0.0
neuro symptoms,0.05
body height,0.0
bowel sounds,0.0
dislocation,0.0
phobia,0.1
other eye problems,0.0
midodrine,0.0
antivirals,0.1
bursitis,0.0
psa,0.0
pulmonary heart disease,0.2
pulmonary function testing,0.85
regional enteritis,0.0
persistent vomiting,0.05
anesthesia,0.05
pathology,0.1
hemolysis,0.0
lyme disease,0.0
duration time 1,0.0
menthol,0.2
anorexia,0.05
intubation,0.3
smoking history,0.25
blood ur,0.0
epres,0.0
beta tester,0.0
difficulty in walking,0.05
need for isolation,0.05
intubated,0.3
patient body temperature,0.0
ribavirin,0.01
heart valve disorders,0.0
appearance,0.0
impella position,0.0
living situation,0.0
airway location,0.2
prevacid,0.0
myelemia,0.0
urine urea,0.05
colon cancer,0.0
inhibition percentage,0.05
barometric pressure,0.1
septicemia,0.0
airway problems,0.75
pain present,0.05
traumatic amputation,0.0
anca test,0.1
polys,0.1
restlessness,0.2
ventilator,0.5
down syndrome,0.0
farr test,0.1
v-neck,0.0
t3 duration,0.05
trach care,0.1
unasyn,0.0
joint effusions,0.05
csf tracking,0.0
lumbar,0.0
aso,0.0
latent tuberculosis,0.05
psoriasis,0.0
myopia,0.0
myocarditis,0.05
furosemide,0.1
diuretics,0.1
digoxin,0.0
morphine,0.0
sepsis,0.0
bronchial,0.85
cocaine,0.0
methamphetamine,0.0
insulin,0.0
respiratory,0.5
marijuana,0.1
methadone,0.05
cannabis,0.1
prolactin,0.05
gout,0.0
atherosclerosis,0.0
aldosterone,0.05
cotinine,0.1
etanercept,0.1
leptin,0.05
hypothyroidism,0.0
hypoglycemia,0.0
calcitonin,0.05
isoproterenol,0.85
influenza,0.1
medication,0.5
hyperglycemia,0.05
haloperidol,0.0
alport,0.0
dopamine,0.0
cd2,0.0
estrogen,0.0
levodopa,0.0
rsv,0.1
ketamine,0.1
losartan,0.1
histamine,0.25
endometriosis,0.0
cachexia,0.05
clozapine,0.0
appetite,0.0
doxorubicin,0.0
Blood,0.0
tacrolimus,0.1
airway type,0.2
respiratory abnormalities,0.65
chest,0.2
breaths,0.1
ambulatory aid,0.1
nebulizer,0.85
respiratory arrest,0.25
inhaler,1.0
bronchoscopy,0.5
respiratory supplies,0.5
aerosol vector air,0.1
respiratory complications,0.65
invasive ventilation,0.5
allergy prescription communication,0.25
cough assist,0.4
rigid bronchoscopy,0.25
medications,0.5
sputum source,0.25
incentive spirometry,0.25
diagnosis,0.0
acute cough,0.65
breatherite,0.85
ventilation measurement,0.65
eosinophilic asthma,1.0
analysis,0.0
respiratory effort,0.25
medication prescribed,0.75
respiratory signs and symptoms,0.75
current dyspnea assessment,0.85
internal communication allergy,0.25
activity,0.1
formula,0.0
drain,0.0
therapeutic actions,0.1
analyses,0.0
device,0.0
ventilation mode,0.2
respiratory pattern,0.25
acute pulmonary heart disease,0.25
cough type,0.25
assist device,0.1
respiratory culture,0.2
treatment,0.5
inspiratory ratio,0.25
wood dust,0.25
speech,0.0
audit,0.0
tablet,0.0
equipment,0.1
sputum consistency,0.25
ventilation rate,0.25
par-respiration,0.2
viral pneumonia,0.1
ed,0.0
dimension,0.0
state,0.0
cough reflex,0.25
context,0.0
ana comment,0.0
resolution,0.0
cough/deep breath,0.25
"cough, unspecified",0.5
resp alarm - high,0.2
chest pain,0.25
respiratory insufficiency,0.65
painful respiration,0.65
bronchitis and asthma without cc/mcc,1.0
aspergillosis,0.2
extrinsic allergic alveolitis,0.25
dependence on respirator [ventilator] or supplemental oxygen,0.25
resp alarm - low,0.1
bronchial challenge test with a bronchoconstrictor agent or physical factor during a pulmonary function test,0.85
exposure to air pollution,0.65
pulmonary congestion and hypostasis,0.2
hyperventilation,0.25
arteritis nos,0.0
airway size (mm),0.1
angina pectoris,0.0
arrhythmia (cardiac) nos,0.0
hypertension,0.0
nasal congestion,0.25
lung disease due to external agents,0.5
breathing pattern/effort,0.65
"adverse effect: substances acting on the respiratory system, others and unspecified",0.65
breaths setting,0.1
sputum amount,0.25
abnormal sputum,0.75
respiratory infections and inflammations with mcc,0.45
tobacco use,0.3
hemoptysis,0.25
symptoms involving respiratory system and other chest symptoms,0.75
high sensitivity carbon dioxide,0.1
"nebulization of therapeutic agent for bronchial use [aerosol] with monitoring of oxygen saturation by transcutaneous measurement [spo2] and monitoring of heart rate, for at least 2 hours",1.0
hidradenitis,0.0
alcoholism,0.0
idiopathic fibrosing alveolitis,0.1
current smoker,0.25
rheumatoid arthritis,0.0
pulmonary artery pressure alarm - high,0.1
"acquired absence of organ, lung",0.1
cancer within the respiratory system,0.1
torticollis,0.0
"eosinophilia, unspecified",0.25
albuterol 0.083 in 3ml ns (via upmc dme),1.0
eosinophil,0.65
allergic purpura,0.1
eosinophils,0.65
ovalbumin ige,0.25
eosinophilia,0.65
title,0.0
mast cells,0.25
ige allergen ovalbumin,0.65
prednisolone,0.85
l,0.0
fve title,0.0
tuberculosis,0.0
immunology,0.25
nomenclature,0.0
other,0.0
i,0.0
eosinophils %,0.25
peanut allergy,0.1
**hapt,0.0
see below,0.0
s comment,0.0
cortisone,0.75
p comment,0.0
clinical info,0.0
other eosinophilia,0.65
cystic fibrosis,0.1
ige allergen helminthospore,0.25
t comment,0.0
section,0.0
therapy,0.25
eosinophil %,0.3
absolute eosinophils,0.25
risk,0.1
0.4,0.0
"allergen, interpretation",0.65
"ige  dust mite,d.frn",0.85
cardiovascular,0.05
prot asthma pf 1/4,1.0
prot p.asthma f 1/4,1.0
family history of asthma and other chronic lower respiratory diseases,0.85
anxiety,0.1
=albuterol,1.0
proair,1.0
myasthenia gravis,0.0
azelastine / fluticasone,1.0
apremilast,0.0
singulair,1.0
acne aestivalis,0.0
roflumilast,0.85
autism,0.0
bronchial wash amylase,0.2
azelastine nasal product,0.65
family history of other chronic respiratory conditions,0.25
albuterol-ipratropium,1.0
"montelukast, 10 mg tablet",1.0
other diseases of lung,0.5
ige allergen latex,0.25
measles,0.0
azelastine / fluticasone nasal product,0.75
anti-dust mite,0.75
betaxolol,0.1
alclometasone,0.85
montelukast 10 mg oral tablet,1.0
house dust mite,0.75
ige allergen peanut,0.25
abnormal chest sounds,0.65
chronic obstructive pulmonary disease with cc,0.25
"bambuterol - oxeol, 10 mg tablets",0.85
combivent,1.0
second hand tobacco smoke,0.65
bronchopneumonia and lung abscess,0.2
dextromethorphan-guaifenesin,0.25
guaifenesin,0.25
alpha 1 antitrypsin mutation,0.1
r.pcr.c.pneumoresp,0.25
comment(pcr b.per),0.0
olodaterol,0.85
lolium perenne ab.ige.rast class,0.25
indacaterol,0.9
r.pcr.m.pneumoorl,0.2
occupational exposure to dust,0.25
bordetella pertussis,0.1
smooth muscle ab,0.1
influenza a by pcr,0.05
oxygen flow rate l/min,0.25
arformoterol,0.9
r.pcr.b.pertusorl,0.1
influenza a antigen (point of care),0.05
influenza b by pcr,0.05
legionella pneumophila ag,0.05
aclidinium,0.85
spiriva,0.9
umeclidinium / vilanterol,0.9
how.pcr c.pneu,0.25
orthopnea,0.65
disorders of diaphragm,0.1
hypoventilation,0.25
carvedilol,0.05
asphyxia and hypoxemia,0.75
isoflurane,0.1
septic shock,0.0
other cardiomyopathy,0.05
thiopental,0.0
metaproterenol,1.0
myocardial infarction,0.0
aminophylline,0.85
dizziness and giddiness (light-headedness and vertigo),0.1
propafenone,0.0
personal history of allergy to medicinal agents,0.2
cardiogenic shock,0.0
primary pulmonary hypertension,0.1
acidosis,0.2
dexamethasone,0.65
hypertensive heart disease,0.0
hyperhidrosis,0.05
"other diseases of respiratory system, nec",0.25
disorders of the autonomic nervous system,0.1
secondary diabetes mellitus,0.0
alpha-1-antitrypsin deficiency,0.1
alcohol-related disorders,0.0
primary/intrinsic cardiomyopathies,0.0
potassium iodide,0.01
other ill-defined and unknown causes of morbidity and mortality,0.1
cyproheptadine,0.1
bethanechol,0.1
pyelonephritis,0.0
arterial blood gases,0.25
abnormal results of function study of pulmonary system,0.75
unstable angina (intermediate coronary syndrome),0.0
atrial fibrillation,0.0
flunisolide,0.9
"hiv infection, symptomatic",0.0
voice disturbance,0.1
fluticasone / vilanterol,1.0
aspergillus niger ige,0.25
neomycin / polymyxin b / prednisolone,0.25
total partial pressure of carbon dioxide,0.1
total partial pressure of oxygen,0.1
house dust greer ige,0.75
shunt assessment lab test,0.05
streptococcus pneumoniae ab,0.05
adenovirus dna,0.05
budesonide / formoterol / glycopyrronium,1.0
fluticasone topical product,0.2
beclomethasone nasal product,0.25
fluticasone / umeclidinium / vilanterol,1.0
mometasone topical product,0.2
flunisolide nasal product,0.25
budesonide nasal product,0.25
fluticasone nasal product,0.25
mometasone nasal product,0.25
oxyhemoglobin concentration,0.1
other laboratory: sulfatide sulfate,0.05
albuterol_.83_mg/ml_3_ml_sol,1.0
other disorders of liver,0.0
abnormal findings examination of lungs,0.65
other symptoms,0.1
chlorpheniramine,0.75
short stature,0.05
shock,0.05
disease of capillaries,0.05
iddm patient ql,0.1
budesonide 0.5mg/unit dose (via upmc dme),0.85
upper resp disease profile,0.4
avocado (persea americana) ige,0.25
tryptase level test,0.1
azelastine ophthalmic product,0.1
prescription date,0.0
eosinophilic esophagitis,0.1
plasma histamine,0.25
oyster (ostrea edulis) ige,0.2
upper respiratory allergy region 1,0.25
rye (secale cereale) ige,0.2
aspergillus fumigatus ab.ige.rast class,0.25
peach (prunus persica) ige,0.25
strawberry (fragaria vesca) ige,0.1
pineapple (ananas comosus) ige,0.2
histamine assay,0.25
Amoxicillin IgE,0.1
tryptase,0.1
e204 alb. cow serum,0.05
dermatophagoides farinae ab.ige.rast class,0.25
cynodon dactylon ab.ige.rast class,0.1
common pigweed ige,0.65
wheat (triticum aestivum) ige,0.25
cat dander ab.ige.rast class,0.85
formoterol fumarate,1.0
or received,0.0
isoetharine,0.85
bacterial pneumonia,0.1
albuterol 0.833 mg/ml / ipratropium bromide 0.167 mg/ml inhalation solution,1.0
"tiotropium / olodaterol - spiolto respimat, 2.5 mcg/2.5 mcg/dose, inh sol, bottle 60 doses",0.85
device efficiency percentage,0.0
neuronal nuclear ab,0.0
sars-cov-2 (covid-19) ab,0.1
ionized calcium,0.05
l-methylfola tab 15mg,0.05
influenza a virus a/north carolina/04/2016 (h3n2) antigen / influenza a virus a/singapore/gp1908/2015 (h1n1) antigen / influenza b virus b/iowa/06/2017 antigen / influenza b virus b/singapore/inftt-16-0610/2016 antigen,0.0
2282 del4 polymorph,0.05
sperm survival test,0.0
expected turnaround time (karyotyping),0.0
closed reduction and internal fixation of fracture or epiphyseal detachment of the proximal end of the tibia or both bones of the leg,0.0
unspecified overexertion and strenuous and repetitive movements or loads,0.1
conclusion,0.0
ornithine,0.0
troponin t.cardiac,0.0
uranium sodium,0.0
spermatozoa.normal/100 spermatozoa,0.0
denaturation,0.0
ige allergen sheep sorrell,0.25
"dpca balance, 1.5% glucose, ca 1.75, ph=7, 2l stay-safe (ref f00007858)",0.0
mgb comments,0.0
=sodiumthiosulfate,0.0
"parenteral nutrition: clinimix n14 g30, 2 l bag",0.0
heterophile ab,0.05
conivaptan,0.05
cashew nut,0.1
flow (vad),0.05
ric placed in outside facility,0.05
lysosomal storage diseases,0.0
detection sensitivity limit,0.0
acanthocytes,0.0
32 weeks gestation of pregnancy,0.05
carisoprodol,0.05
calcium/sodium alginate,0.05
"perikabiven 1 200 kcal/1 920 ml, emulsion for infusion, tri-compartment biofine bag",0.0
"vacuum-assisted core biopsy of breast lesion using add-on system, percutaneous approach with mammographic guidance",0.0
"sympathyl, coated tablets",0.1
bortezomib,0.0
total protein concentration in blood,0.05
iga.lambda,0.0
saint louis encephalitis virus igg,0.0
"supraselective in situ hepatic intra-arterial injection of non-radioisotope anticancer pharmacological agent with particle embolization, via transcutaneous arterial route",0.0
sustiva,0.0
nil,0.0
ergocalciferol 1.25 mg oral capsule,0.05
citric acid - dextro-citric acid,0.05
etodolac,0.0
deoxyhemoglobin,0.1
"pedal cycle driver injured in noncollision transport accident in traffic accident, initial encounter",0.0
"letrozole 2.5 mg (femara), tablets aip bba be",0.0
ca / creatinine ratio,0.05
fer-gen-sol,0.0
pressure ulcer #3- cleanse,0.0
tacro t 2,0.0
krill oil,0.05
impact caused by the throwing or dropping of an object - home,0.0
fentanyl plasma concentration,0.05
age patient (years),0.0
5 ml protamine sulfate (usp) 10 mg/ml injection,0.05
hepatitis c virus antibody,0.0
esketamine,0.1
valine csf,0.05
dexmedetomidine400mcg/d5w100mlpmx(cabinetus,0.0
jc virus dna,0.0
hcv rt-polymerase chain reaction (qual),0.0
chromosomal anomalies,0.0
cd24+,0.0
"herpes simplex virus 2 deoxyribonucleic acid by polymerase chain reaction qualitative, cerebrospinal fluid",0.0
"unruptured infrarenal aortic aneurysm repair with infrarenal aorto-aortic prosthetic replacement, by laparotomy with suprarenal clamping",0.0
calculated o2 saturation,0.25
dibucaine 0.01 mg/mg topical ointment,0.0
"suturing of wound of abdominal aorta, of a common iliac artery and/or of an external iliac artery, by laparotomy",0.0
follicle stimulating hormone test,0.0
aggrenox_capsule_er,0.0
gelatinsponge12/7mm,0.0
sanger sequencing for point mutation detection,0.05
glucose tolerance fasting (do not order alone),0.0
infliximab,0.1
gi_cocktail_(smh)_30ml,0.0
"cutaneous gastrostomy, by laparotomy",0.0
urine acetaminophen,0.0
thyroid uptake test,0.0
occult blood fecal immunochemical test single screen,0.0
mestranol / norethindrone,0.0
"orbital lesion biopsy, via lateral or ethmoidal approach",0.0
preliminary b cell type and crossmatch interpretation,0.0
total cd34+ (%),0.1
placement of an intra-arterial pressure monitoring device,0.0
succinate,0.0
clinical probability score,0.1
pancreatic polypeptide,0.01
methyl-1 histidine s,0.0
Fatty acids.nonesterified,0.0
gds origin,0.0
platelet factor 4,0.05
"change of an esophageal endoprosthesis, by endoscopy",0.0
"hysterectomy for obstetric complications, by laparotomy",0.0
one tch lanc del plus dev,0.0
california walnut pollen (juglans california pollen) ige,0.25
pruritus and related conditions,0.05
influenza a/b pcr test,0.1
spasm of muscle,0.1
multiple gestation,0.0
unspecified residential institution as the place of occurrence of the external cause,0.0
"binimetinib - mektovi, 15 mg tablet",0.0
Sapovirus RNA,0.0
"placement of a stent in a previously drained biliary duct, with ultrasound and/or radiological guidance",0.0
alpha rapid thromboelastography with heparinase,0.0
cd45ro/ra+cd3 normal control percent,0.05
inactivity osteoporosis with pathological fracture - arm,0.0
platelet function,0.05
lymphocyte count test #4,0.1
viability by propidium iodide,0.0
"nonspecific abnormal findings on radiological and other examination of other intrathoracic organs (echocardiogram, etc)",0.1
isoleucine,0.0
"central hepatectomy, by laparotomy",0.0
nonspecific findings on examination of blood,0.1
ige allergen cor a 14,0.65
hydroxychloroquine,0.05
"firearm and other weapon assault, and sai - home",0.0
doxycycline,0.0
extensive and/or tight pelvic peritoneal adhesion release [adhesiolysis] for female infertility by laparoscopy,0.0
ascitic fluid ldh,0.05
immature reticulocyte fraction percentage,0.0
whitescreen,0.0
coxsackievirus b6 ab,0.05
peanut (arachis hypogaea) native (nara h) 2 ige,0.2
penicillin g benzathine / penicillin g procaine,0.0
undermining present #1,0.0
Plasmodium vivax DNA,0.0
cultural outing,0.0
supplement for the use of custom and focused caches,0.0
acetaminophen,0.0
utx4,0.0
stx5,0.0
serum calcium adjusted for albumin,0.05
crizotinib,0.0
white blood cell clump count per high power field,0.1
bartonella henselae dna,0.0
lct o/n,0.0
daclizumab,0.1
biological validation,0.0
urgent cmv igm,0.0
type 2 crystals,0.05
institute for forensic research,0.0
Coproporphyrin 1/Creatinine,0.05
low-density lipoprotein cholesterol calculated,0.05
igm csf level,0.05
diuresis,0.05
surnamefirstname pat.example,0.0
euglobulin lysis time,0.05
occult blood test - 2,0.0
"resection of a tumor of the anterior floor of the skull base, via unilateral frontal craniotomy",0.0
sodium l-ascorbate,0.05
deprecated n-ac-asp ur ql,0.0
iron-binding capacity total,0.05
"excision of vestigial thymus, by thoracotomy",0.05
"fall from scooter (nonmotorized), initial encounter",0.0
"influenza a virus vaccine, a-victoria-361-2011 (h3n2)-like virus / influenza a-california-7-2009-(h1n1)v-like virus vaccine / influenza b virus vaccine, b-massachusetts-2-2012-like virus",0.1
motor vehicle traffic accident of unspecified nature injuring passenger in motor vehicle other than motorcycle,0.0
long term (current) use of hormonal contraceptives,0.05
parainfluenza virus 4 rna,0.1
metering site(s),0.1
pump connect,0.05
Polio virus 1 Ab.Neut,0.0
eprex (epo) 40000iu/ml inj sol vial 1ml,0.0
b-d #9622 syr/ndl 1ml 25gx1,0.0
prothrombin time (pt),0.05
mycobacterium sp,0.0
scan for immature cells,0.05
sympathetic protection v4,0.05
continuous unipolar traction of the spine by strap or collar,0.0
=enalaprilat,0.1
urine white blood cell count - iris,0.05
"transscleral transillumination of lesion of posterior segment of eye, with conjunctival detachment",0.0
diphenhydramine hydrochloride 2.5 mg/ml oral solution [tusstat],0.25
driver - transport accident - without collision - off-road,0.0
sodium ur tp {c,0.0
complement c1 esterase inhibitor,0.05
"skin graft for burns excluding the head and hands, covering 5% to 7.5% of the body surface area",0.0
pre-inc dop-ams prot,0.0
other artificial opening status,0.05
p32,0.1
folates,0.05
"fall on same level due to ice and snow, subsequent encounter",0.0
observation for unspecified suspected condition,0.2
urine density,0.05
"sodium alginate sodium bicarbonate 0.5 g/0.267 g biogaran, oral suspension, sachet 10 ml",0.1
"lopinavir/ritonavir (generic kaletra), 200 mg/50 mg tablets",0.05
chronic lymphocytic leukemia,0.0
terconazole topical,0.0
platelet with cd41,0.05
dexamethasone / tobramycin,0.65
thioridazine,0.05
paroxetine,0.0
methylenedioxymethamphetamine,0.0
excess base ecf,0.1
change of an intrathecal spinal catheter connected to a delivery system or an implanted subcutaneous pump,0.0
meningococcal_(menomune)_vaccine_0.5ml,0.0
